Careless™ improves microcirculation and glucose metabolism in healthy people
Langenfeld, Germany, 16th February 2017, Vital Solutions GmbH, a specialist in natural product development, sales and marketing is pleased to announce that results of a second human study confirmed that supplementation with Careless™ supports microcirculation and glucose metabolism.
Effects on microcirculation and glucose metabolism were investigated in a double-blind, randomized, placebo-controlled, parallel-design study in healthy individuals. A daily dose of 100 mg or 300 mg Careless™ was compared to placebo after supplementation for 4 weeks.
100 mg Careless™ improved microcirculation and confirmed results of the first human study.
300 mg Careless™ reduced postprandial glucose levels accompanied by significantly lower HbA1c values compared to baseline. Furthermore, 300 mg Careless™ intake significantly improved postprandial endothelial function in individuals with decreased endothelial function after high-dose glucose intake.
Dose-depending effects support the use of Careless™ in different applications, said Dr. Sybille Buchwald-Werner, Managing Director at Vital Solutions. For example, Careless™ at a dosage of 100 mg is interesting for products positioned for cardiovascular health or to support physical energy and endurance. Careless™ at a dosage of 300 mg might be beneficial for use in concepts for healthy metabolism.
The study is published in Planta Medica, one of the leading international, peer-reviewed journal in the field of medicinal plants and natural products.
Careless™ is a product of Vital Solutions. Careless™ is a high quality, sustainable natural ingredient, which is IP protected and approved to be used in foods and food supplements.
The study is published in Planta Medica
one of the leading international, peer-reviewed journals in the field of medicinal plants and natural products.